State Street’s Anebulo Pharmaceuticals ANEB Stock Holding History

State Street’s Portfolio ANEB Stock Details ANEB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,768	Closed	-$12.9K	–	4273
2025 Q4	$12.9K	Hold	12,768	–	–	﹤0.01%	4263
2025 Q3	$31.9K	Buy	+12,768	New	+$30K	﹤0.01%	4207

State Street's ANEB Position: Q1 2026 in Review

State Street sold out of Anebulo Pharmaceuticals (ANEB) in Q1 2026, closing a stake of 12,768 shares — an estimated $12.9K sold.

State Street first reported a position in ANEB in Q3 2025 and held it in 2 quarters. The position peaked at $31.9K in Q3 2025. 0 funds tracked by Wall St. Rank hold ANEB as of Q1 2026.

State Street reported no remaining Anebulo Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
State Street sold 12,768 Anebulo Pharmaceuticals shares in Q1 2026, an estimated $12.9K.
State Street first reported a position in Anebulo Pharmaceuticals in Q3 2025 and held it in 2 quarters.
State Street's Anebulo Pharmaceuticals position peaked at $31.9K in Q3 2025.
0 funds tracked by Wall St. Rank held Anebulo Pharmaceuticals as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.